Fleischmann, R., van Adelsberg, J., Lin, Y., Castelar‐Pinheiro, G. d. R., Brzezicki, J., Hrycaj, P., . . . Burmester, G. R. (2017). Sarilumab and Nonbiologic Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors. Arthritis Rheumatol.
Chicago Stili AlıntıFleischmann, Roy, et al. "Sarilumab and Nonbiologic Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors." Arthritis Rheumatol 2017.
MLA AlıntıFleischmann, Roy, et al. "Sarilumab and Nonbiologic Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors." Arthritis Rheumatol 2017.